Cockrell School of Engineering Global Championship
David C. Bonner, Chairman and CEO, of StematixTM, Inc., has extensive experience in executive business management globally as well as technology development, including a successful medical system commercialization. He has led seven start-up ventures and has extensive world-wide licensing experience. Dr. Bonner earned his B.S. and M.S. degrees in Chemical Engineering from the University of Texas at Austin, and completed his Ph.D. degree in Chemical Engineering at the University of California, Berkeley. He was named a Distinguished Engineering Graduate of the University of Texas in 2001.
R. Scott Evans is the Vice President for Business Development at Pretium Innovation, a company that creates faster, lower risk and higher return innovation with Crowd Innovation™ techniques, methods and software. They also actively commercialize early-stage technology through their Pretium Ventures arm. Before joining Pretium, Dr. Evans instructed cross-listed graduate-level courses in technology commercialization and coordinated the Idea to Product® technology commercialization program. He co-founded a materials and manufacturing company based on his Ph.D. research, which partially funded his doctoral studies. His industrial experience includes manufacturing and product engineering for Reynolds Industries and Thermax/CDT, Inc. His research at The University of Texas and Georgia Tech included technology entrepreneurship, product design, MEMS, materials science and manufacturing.
Jerri L. Paul has worked in product and business strategy for more than 15 years. Jerri is currently a consultant with SynEnergy Associates working with start-up and early stage companies in the technology commercialization and energy sectors. She leads a team of management consultants for manufacturing, operations, marketing, product development, planning and strategy. Formerly, Ms. Paul was President & CEO of a small software company in Austin providing an electronic health record solution for a niche healthcare market where she executed a turn-around leading to the sale of the company. She has also provided management consulting to several companies, venture capitalists, and angel investors. Jerri honed her business savvy as a business and product strategy specialist with Ford Motor Company in Dearborn, Michigan . She holds a B.S. in Mechanical Engineering, M.S. in Manufacturing Systems Engineering, and M.B.A. in Operations Management from the University of Texas at Austin.
Jack Richards received a B.S. in biomedical engineering from Texas A&M. For the next four years he worked as an engineer at a start-up medical device company that made novel cardiology monitoring equipment. The company grew until it was acquired by GE Medical Systems. Jack next went to law school to become a patent attorney. He now practices at Trop, Pruner & Hu, P.C. in Austin, Texas where he obtains and litigates patents and trademarks. Jack handles medical device, electrical, software, and mechanical work for start-ups and large corporations including Intel, Spinal Restoration, Scott & WhiteHospital, SiLabs, and others. Jack has a forgiving wife and 2 kids.
David Schieck's professional career spans technology oriented leadership positions in industry, government and the academic sectors. David has participated in numerous commercialization assessment and strategic planning efforts for technologies ranging from medical stents, cancer treatments, drilling apparatus, to revolutionary new engines. David was one of the founders of the I2P™ Competition and has served as Program Director for the Chair of Free Enterprise, University of Texas at Austin. Currently he provides technology commercialization services through ERSON Consulting.
McCombs School of Business Global Championship
Ray Atilano serves as a Licensing Specialist for the Office of Technology Commercialization at The University of Texas at Austin. In this role, he evaluates commercial opportunities of life science inventions, markets technology to potential partners, guides investment strategy in patent prosecution, and negotiates intellectual property licenses. Dr. Atilano brings more than 12 years of experience in evaluating research, presenting technologies to venture groups, angel investors, and companies, marketing early-stage inventions, and negotiating licensing. Most recently, he worked as a technical project director to support the Department of Defense, Air Force Research Labs in a Bio Safety Level 3 Laboratory on commercializing advanced biomaterials, biochem sensors, and product applications as a result of SBIRs and related DoD contractor initiatives. Previously, he held a technical management position with a startup micro-optoelectronic technology company, which spun out of his work as a technical project director with a private foundation focused on biotechnologies, biomedical devices, and prototype development. He has represented the technology of subject matter experts at previous Trilateral Technology and Bio-Defense Summit Meetings, and to the Under Secretary of Defense, DISA, NRO, and NSA. Dr. Atilano is a Texas Certified Civil & Commercial Negotiator from the Dallas Mediation Institute, and holds a B.S. from IllinoisStateUniversity and an M.S. and a Ph.D. from KansasStateUniversity. He also holds a Management Certificate from TexasStateUniversityCenter for Health Services Education & Research.
Ross Garsson is a partner in Matheson Keys Garsson & Kordzik PLLC in Austin, Texas. His legal practice focuses on intellectual property and technology law with an emphasis on litigation, patent prosecution, and intellectual property portfolio management in a variety of technology areas, including chemical (from polymer science to biochemistry), nanotechnology, semiconductor, and computer technologies. Ross is recognized as one of the leaders in the field of nanotechnology. He has worked closely with nanotechnologists to procure and license their technologies, and his work assisting scientists at the Richard E. Smalley Institute for Nanoscale Science and Technology at RiceUniversity and the Alan G. MacDiarmid Nanotech Institute at the University of Texas at Dallas has resulted in some of the most important patents for producing and manipulating carbon nanotubes. Mr. Garsson is currently on the Board of the Rice Alliance for Technology and Entrepreneurship (Houston) and the Steering Committee of the Austin Rice Alliance. He is also on the Board of Directors of the AustinGiftedSchool (AceAcademy). Ross received his J.D. degree from the University of Texas after earning a B.S. degree in Chemical Engineering and a B.A. degree in Mathematics from RiceUniversity.
Jack Hart received his Ph.D. in Aerospace Engineering from The University of Texas at Austin. After graduation, he joined the Central Intelligence Agency in Washington, D.C. where he served for 7 years. Jack then returned to Austin and spent the next 17 years at Radian Corporation in the Special Projects Department where he ultimately served as a Department Head. Jack was instrumental in building the Department from 4 members to more than 50 and expanding both the technology base and the client base. Jack has also served as Program Director in a Dr. George Kozmetsky start-up company that commercialized Global Positioning System (GPS) technology for the telecommunications industry. He has been in his current position of Assistant Chairman in The University of Texas Department of Biomedical Engineering for more than five years. Jack supports the Chairman in attaining the numerous goals of the Department and also serves as the Department’s liaison to the biotechnology industry in Texas.
Gregory Pogue serves as Vice President of Business Development at Emergent Technologies, Inc. (ETI), where he serves as President and Managing Director of Receptor Logic, Inc., Pure Vaccine Solutions, LLC and MHC Biologics, LLC portfolio companies. In his ETI position, Dr. Pogue evaluates the commercial potential of new technologies, determines both technical and market trajectories, and builds partnerships to effectively commercialize products. Dr. Pogue brings over twenty years of experience in biologic development, spanning research management, biologic regulation, and intellectual property development and licensing. Dr. Pogue has executed licensing, R&D and equity investment deals totaling $65M in value. Most recently, Dr. Pogue served as Licensing Associate for the University of Texas at Austin where he negotiated licenses with companies ranging from newly formed startups to Fortune 500 enterprises. Before coming to Texas, Dr. Pogue served as Vice President of Research and Development at Large Scale Biology Corporation, where he managed a broad development program involving product development and preclinical and clinical testing of numerous lead compounds, including two receiving Orphan Drug Designation from the FDA and 16 successfully completing early clinical trials. He also developed licensing and R&D contracts with corporate, academic, and government entities and supervised collaborative research relationships. Before joining LSBC, Dr. Pogue worked in the FDA's Center for Biologics Research and Evaluation as a scientist with Investigational New Drug and Biological Licensing Application review responsibilities.
John Wheeler is the Director of Product Development and Marketing at Spinal Restoration. John was formerly the director of U.S. Knee Marketing at Zimmer, Inc. where he led a team responsible for the $850 million artificial knee franchise. Mr. Wheeler has more than 15 years experience in the orthopaedic industry and has held a variety of management positions in marketing, engineering and business development. John has enjoyed a successful and diverse career. He has been assigned several patents involving orthopaedic designs and enjoys working with physicians to help provide better patient care. Additionally, John has a passion for strategy development and implementation with a focus on marketing aspects. John has brought numerous medical products to market and was directly responsible for pioneering a direct-to-patient marketing and publicity campaign that reached over 17 million television viewers in a 3 month period. John Wheeler holds a B.S. in Bioengineering from TexasA&MUniversity (Magna Cum Laude) and an M.B.A. from BaylorUniversity.
Technology Entrepreneuship Society Global Championship
Bart Bohn is the Director of the ATI Wireless and Information Incubators. He is responsible for identifying promising early stage companies and providing them with the necessary strategic business assistance needed to help them achieve their growth objectives. Bart has significant experience in advising companies on strategic issues and working with executive teams to identify and pursue strategic objectives. Before joining ATI, Bart was an engagement manager with BearingPoint consulting and advised clients on strategy, strategy development, strategy implementation and business process design. He was the founding engagement manager of BearingPoint's Energy Strategy practice and was responsible for designing the methodologies for the core offerings and building the team. In addition to serving energy clients, he served clients in the professional services, software, banking, and utilities industries. Bart is the Executive Director of the Austin Wireless Alliance, a non-profit association promoting the growth of the wireless industry in Central Texas and on the Planning Board for MobileMonday Austin. Additionally, Bart serves on the board of Turn2Live, a live music oriented Austin startup. Bart holds a MBA from The University of Texas at Austin, a BS in Chemical Engineering and a BS in Finance from TrinityUniversity.
Jitendra Jain serves as a Licensing Specialist for the Office of Technology Commercialization (OTC) at The University of Texas at Austin. His focus in this role is to protect and to accelerate the commercialization of the university’s physical sciences, engineering, and computing intellectual assets. Mr. Jain specializes in commercially assessing and valuating technologies, cultivating inventions, developing intellectual property (IP) positions, guiding investments in patent prosecution, developing commercialization strategies, nurturing industry/venture-capital relations, marketing to prospective licensees, assisting in the formation of startups, and negotiating complex IP-based collaborative agreements to monetize IP. Mr. Jain brings over 14 years of domestic and international experience in academic technology transfer, product marketing, entrepreneurship, and business development spanning the computing, telecom, and semiconductor industries. Prior to joining the OTC in February 2008, Mr. Jain served as a Senior Licensing Associate at OhioStateUniversity, successfully commercializing engineering properties. Previously, Mr. Jain worked as a Product Marketing Manager for the Communications Group at Advanced Micro Devices (spun out as Legerity), managing voice and broadband integrated chipsets. Later, Mr. Jain ventured into creating his own large-scale events production house and a related web portal. Mr. Jain has also worked as an Associate for the OTC at the TexasA&MUniversity, and as a Sales Manager for Wipro Infotech’s Business Solutions Division, providing turnkey information technology solutions to Fortune 500 clients. Mr. Jain holds a B.S. in Electrical Engineering and an M.B.A. from TexasA&MUniversity.
Hall Martin is the Director of the Austin Entrepreneur Network based in Austin, Texas, providing assistance for startup and early stage companies. He serves on the board of the Baylor Angel Network. Previously he served as the Director of the Central Texas Angel Network where he established the network and grew the membership to 50+ with $4.5M invested in 20 deals. Hall T. Martin has worked at National Instruments for over twenty years in various positions including Corporate Development Director, Emerging Technologies in which he focused on research into new technologies and markets. Other positions at National Instruments include Market Development Director, International Marketing Manager, and European Sales Manager. He joined the company in 1986 as an Applications Engineer. He holds a B.A. in computer science from BaylorUniversity and an M.B.A. from the University of Texas at Austin. He is a member of Upsilon Phi Epsilon, the Computer Science Honor Society. He has a wife named Victoria, and they have a daughter named Lili.
Becky Taylor is General Partner of Taylor-Deininger Partners, Inc., a business strategy and technology forecasting firm serving the semiconductor, software and venture capital industries. Prior to forming TD Partners, Ms Taylor was Director of Software Platforms at Advanced Micro Devices’ Personal Connectivity Solutions division, where she formed its software organization creating products you use in your wireless network, PDA, and digital TV. Prior to joining AMD, Becky was President/CEO of various startups and consultancies, notably Terrace Mountain Systems, where she provided software strategy and design services to the Global 2000, on four continents. Ms. Taylor is a Senior Member of the IEEE, holds four patents and has a BS in Computer Science. She has lived in Austin since 1984, is a committed University of Texas football fan, and is a private pilot. She has one son, Daniel, a sophomore in college. Her board service includes election as a director of TruWest Credit Union, and AustinCommunity College’s Foundation Board, where she is chair of the Board Development Committee.
Carol Williams spent 20 + years in Electronic Distribution working with Technology companies. In 1995, she started Trendsetter Electronics, an electronic technology distributor. Trendsetter currently does business worldwide and enjoys Strategic Partnerships with National Instruments, Schlumberger and other Fortune 100 customers.
Christopher Stanley is the Chief Business Officer and Co-Founder of RxGen, Inc., a specialty preclinical research organization focused on the research and development of therapeutic, medical device, and drug delivery technologies. Mr. Stanley has broad responsibility for business and corporate development as relates to contract research services, licensing, strategic partnerships, and financing activities. Prior to co-founding RxGen, Mr. Stanley was at Accenture where he managed strategic planning, due diligence, and corporate development opportunities related to venture and strategic investments and cross-border outsourcing engagements. Prior to joining Accenture, Mr. Stanley worked for JPMorgan Chase in New York in Global Capital Markets.